Colorectal cancer-derived exosomes and modulation KRAS signaling
Yan Hua Wan1, Qi Sheng Liu1, Sha Sha Wan2
1Three Branches of General Surgery, JiuJiang First People's Hospital, Jiujiang, Jiangxi, China.
Summary
Colorectal cancer (CRC) progression involves exosomes modulating Kirsten rat sarcoma virus (KRAS) signaling. This review summarizes recent findings on how CRC-derived exosomes impact KRAS pathways, crucial for cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Colorectal cancer (CRC) is a leading cause of cancer mortality globally.
- Approximately 30% of CRC patients present with metastases at diagnosis, facing poor prognoses.
- CRC development is linked to accumulating mutations in oncogenes and tumor suppressor genes.
Purpose of the Study:
- To review recent discoveries on exosome-mediated modulation of Kirsten rat sarcoma virus (KRAS) signaling in colorectal cancer.
- To understand the role of exosomes in CRC pathogenesis and progression.
Main Methods:
- Literature review of studies investigating exosomes and KRAS signaling in CRC.
- Analysis of research on exosome biogenesis and cargo in cancer cells.
- Examination of experimental data on exosome effects on signaling pathways.
Main Results:
- Tumor cells release exosomes in response to oncogenic mutations.
- Exosomes can inhibit critical signaling pathways, including the KRAS pathway.
- Exosomes derived from colorectal cancer have demonstrated the ability to induce CRC in animal models.
Conclusions:
- Exosomes play a significant role in the modulation of KRAS signaling in colorectal cancer.
- Understanding exosome-KRAS interactions is vital for developing novel therapeutic strategies for CRC.
- Targeting exosome-mediated KRAS signaling may offer new avenues for CRC treatment.
Related Concept Videos
02:38The Ras Gene
6.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.4K
01:36Overview of Exosomes
2.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K
01:24Small GTPases - Ras and Rho
4.2K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.2K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K